Recent News

• 02.11.2026 - Royalty Pharma Reports Q4 and Full Year 2025 Results
• 01.20.2026 - Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
• 01.12.2026 - Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference
• 01.11.2026 - Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
• 01.09.2026 - Royalty Pharma Announces Dividend Increase

Recent Filings

• 02.11.2026 - EX-99.1 EX-99.1
• 02.11.2026 - 8-K Current report
• 02.11.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.20.2026 - 144 Report of proposed sale of securities